Harvard Bioscience Inc (HBIO)

2.295 +0.12 (+5.76%) USD  |  NASDAQ  |  Nov 14, 16:00
2.295 0.00 (0.00%) After-Hours: 20:00
More

Harvard Bioscience Research and Development Expense (Quarterly): 2.567M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2001. Upgrade now.
Date Value
September 30, 2024 2.567M
June 30, 2024 2.626M
March 31, 2024 2.885M
December 31, 2023 3.15M
September 30, 2023 2.76M
June 30, 2023 2.957M
March 31, 2023 2.897M
December 31, 2022 2.849M
September 30, 2022 2.763M
June 30, 2022 3.497M
March 31, 2022 3.22M
December 31, 2021 2.951M
September 30, 2021 2.66M
June 30, 2021 2.701M
March 31, 2021 2.487M
December 31, 2020 2.349M
September 30, 2020 1.949M
June 30, 2020 1.897M
March 31, 2020 2.49M
December 31, 2019 2.645M
September 30, 2019 2.564M
June 30, 2019 2.771M
March 31, 2019 2.735M
December 31, 2018 3.045M
September 30, 2018 2.783M
Date Value
June 30, 2018 2.758M
March 31, 2018 2.402M
December 31, 2017 1.526M
September 30, 2017 1.538M
June 30, 2017 1.296M
March 31, 2017 1.285M
December 31, 2016 1.156M
September 30, 2016 1.309M
June 30, 2016 1.502M
March 31, 2016 1.425M
December 31, 2015 1.532M
September 30, 2015 1.426M
June 30, 2015 1.714M
March 31, 2015 1.748M
December 31, 2014 1.564M
September 30, 2014 1.059M
June 30, 2014 1.284M
March 31, 2014 0.973M
December 31, 2013 1.118M
September 30, 2013 1.101M
June 30, 2013 0.922M
March 31, 2013 1.013M
December 31, 2012 -1.205M
September 30, 2012 1.861M
June 30, 2012 1.972M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

1.897M
Minimum
Jun 2020
3.497M
Maximum
Jun 2022
2.715M
Average
2.730M
Median

Research and Development Expense (Quarterly) Benchmarks

Bruker Corp 98.10M
Azenta Inc 7.913M
Bionano Genomics Inc 6.831M
Akoya Biosciences Inc 5.288M
Singular Genomics Systems Inc 10.73M